Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.20 -1.37 (-4.80%)
At close: Oct 23, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Other non-cash items (2021 - 2026)

Updated

Analysis

Amylyx Pharmaceuticals (AMLX) Other non-cash items (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Amylyx Pharmaceuticals 3.03 Bn 1.83 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31,000.00
Mar 31, 2026 53,000.00
Dec 31, 2025 -433,000.00
Jun 30, 2025 264,000.00
Dec 31, 2024 131,000.00
Jun 30, 2024 805,000.00
Mar 31, 2024 22,000.00
Sep 30, 2021 -10.19 Mn
Jun 30, 2021 3.31 Mn
Mar 31, 2021 -2.18 Mn
API Access

Amylyx Pharmaceuticals Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=AMLX&period=max&api_key=YOUR_API_KEY